The historical rank and industry rank for DIH Holding US's Gross Margin % or its related term are showing as below:
DHAI's Gross Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 51.985 * Ranked among companies with meaningful Gross Margin % only.
DIH Holding US had a gross margin of 47.17% for the quarter that ended in Mar. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for DIH Holding US was 0.00% per year.
DIH Holding US (OTCPK:DHAI) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
DIH Holding US had a gross margin of 47.17% for the quarter that ended in Mar. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
DIH Holding US Gross Margin % Related Terms
DIH Holding US Gross Margin % Historical Data
* Premium members only.
The historical data trend for DIH Holding US's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, DIH Holding US's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DIH Holding US Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, DIH Holding US's Gross Margin % distribution charts can be found below:
* The bar in red indicates where DIH Holding US's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
DIH Holding US (DHAI) has a Gross Margin % of 47.17% as of Mar. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on DIH Holding US and its competitors.
Is DIH Holding US's Gross Margin % too high?
DIH Holding US's current Gross Margin % is 47.17%. The Medical Devices & Instruments industry median Gross Margin % is 51.99. DIH Holding US's value of 47.17% is 9.3% below this industry median.
How does DIH Holding US's Gross Margin % compare to ABT and SYK?
DIH Holding US's Gross Margin % of 47.17% can be compared against companies in the Medical Devices & Instruments industry. The industry median Gross Margin % is 51.99. DIH Holding US's value of 47.17% is 9.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.99, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DIH Holding US's current Gross Margin % of 47.17% is 9.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on DIH Holding US and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DIH Holding US's current Gross Margin % is 47.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current Gross Margin % of 47.17%. The current Gross Margin % is 47.17% and 9.3% below the Medical Devices & Instruments industry median of 51.99. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For DIH Holding US (DHAI), the current Gross Margin % is 47.17% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHAI has been successfully added to your 